Phase 2 trial of induction with dasatinib and consolidation with hyper-CVAD plus dasatinib followed by allografting for Ph-positive acute lymphoblastic leukemia in adults-Reference-Cited by-同舟云学术

Phase 2 trial of induction with dasatinib and consolidation with hyper-CVAD plus dasatinib followed by allografting for Ph-positive acute lymphoblastic leukemia in adults

Published:2024-02 Issue: Volume:137 Page:107438
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Oh Iekuni,Hatano Kaoru,Ikeda Takashi,Toda Yumiko,Minakata Daisuke,Kawaguchi Shinichiro,Morita Kaoru,Yamamoto Chihiro,Ashizawa Masahiro,Sato Kazuya,Kameda Kazuaki,Gomyo Ayumi,Misaki Yukiko,Kawamura Shunto,Kimura Shunichi,Kobayashi Hiroyuki,Sato Hiroyuki,Nakasone Hideki,Ohmine Ken,Fujiwara Shinichiro,Kako Shinichi,Kanda Yoshinobu

Publisher

Elsevier BV

Reference20 articles.

1. Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study;Takeuchi;Leukemia,2002

2. Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study;Jinnai;Int. J. Hematol.,2010

3. Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993

4. Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate;Thomas;Blood,2004

5. High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group;Yanada;J. Clin. Oncol.,2006